Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 1,173 of the 1,177 references it cites were found in a registry or an index.

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Open access

Abstract

AIM: The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease” provides an update to and consolidates new evidence since the “2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease” and the corresponding “2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease.” METHODS: A comprehensive literature search was conducted from September 2021 to May 2022. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: This guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. Relevant topics include general approaches to treatment decisions, guideline-directed management and therapy to reduce symptoms and future cardiovascular events, decision-making pertaining to revascularization in patients with chronic coronary disease, recommendations for management in special populations, patient follow-up and monitoring, evidence gaps, and areas in need of future research. Where applicable, and based on availability of cost-effectiveness data, cost–value recommendations are also provided for clinicians. Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001168

Cites

1173 of 1173 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1,177 references

Research works printed but not linked: 142

  1. 10.1161/CIR.0000000000000042 · DOI · Paper page
  2. Wright, RS, Anderson, JL, Adams, CD, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:e426–e579.
  3. 10.1161/cir.0b013e318277d6a0 · DOI · Paper page
  4. 10.1161/cir.0b013e318277d6a0 · DOI · Paper page
  5. 10.1161/CIR.0000000000001029 · DOI · Paper page
  6. 10.1161/CIR.0000000000001038 · DOI · Paper page
  7. 10.1056/NEJMoa0805796 · DOI · Paper page
  8. 10.1001/jamacardio.2019.0035 · DOI
  9. 10.1056/NEJMoa070829 · DOI · Paper page
  10. 10.1056/NEJMoa1915922 · DOI · Paper page
  11. 10.1056/NEJMoa0805796 · DOI · Paper page
  12. 10.1161/CIRCOUTCOMES.118.005079 · DOI
  13. Gulati, M, Levy, PD, Mukherjee, D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e18–e114.
  14. 10.1056/NEJMoa1916370 · DOI · Paper page
  15. 10.1161/01.CIR.0000072790.23090.41 · DOI · Paper page
  16. 10.1093/eurheartj/ehq500 · DOI · Paper page
  17. 10.1007/BF03007355 · doi:10.1007/bf03007355
  18. 10.1007/s12350-012-9548-3 · DOI
  19. 10.1093/ehjci/jez258 · DOI
  20. 10.1161/CIR.0000000000000095 · DOI · Paper page
  21. 10.1056/NEJMoa070829 · DOI · Paper page
  22. 10.1056/NEJMoa1915922 · DOI · Paper page
  23. 10.1056/NEJMoa1916370 · DOI · Paper page
  24. 10.1161/CIR.0000000000000678 · DOI · Paper page
  25. Institute of Medicine. Health Literacy: A Prescription to End Confusion. The National Academies Press; 2004
  26. 10.1001/archinte.1996.00440120070006 · doi:10.1001/archinte.1996.00440120070006 · Paper page
  27. 10.1161/CIR.0000000000000678 · DOI · Paper page
  28. 10.1016/j.jacc.2015.03.550 · DOI
  29. 10.1161/CIR.0000000000000678 · DOI · Paper page
  30. 10.1161/CIR.0000000000001078 · DOI · Paper page
  31. 10.1161/CIR.0000000000000462 · DOI · Paper page
  32. 10.1161/CIR.0000000000000766 · DOI · Paper page
  33. Bhatti, JS, Kaur, S, Bhatti, GK, et al. Genetic susceptibility of vitamin D receptor (VDR) gene variants (BsmI, TaqI and FokI) to coronary artery disease in Asian Indians. Endocr Pract. 2019;25:6A.
  34. 10.1161/CIR.0000000000000019 · DOI · Paper page
  35. 10.1001/jama.289.23.3106 · DOI · Paper page
  36. 10.1161/CIRCULATIONAHA.119.041914 · DOI
  37. Babb S Malarcher A Schauer G et al. Quitting smoking among adults - United States 2000-2015. 2017. 1545-861X (Electronic) 0149-2195. Accessed Jan 6 2021. https://www.ncbi.nlm.nih.gov/pubmed/28056007.
  38. 10.1161/CIR.0000000000000678 · DOI · Paper page
  39. 10.1016/j.jacc.2018.10.027 · DOI · Paper page
  40. 10.1161/CIR.0b013e3182447787 · DOI · Paper page
  41. Rana, JS, Virani, SS, Moffet, HH, et al. Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification. Am J Med. 2021
  42. 10.1161/CIR.0000000000000042 · DOI · Paper page
  43. Institute for Clinical and Economic Review. Alirocumab for treatment of high cholesterol: effectiveness and value: new evidence update. 2019. Accessed March 1 2022. https://icer.org/wp-content/uploads/2020/10/ICER_Alirocumab_Final_NEU_021519.pdf.
  44. 10.1161/CIR.0000000000000625 · DOI · Paper page
  45. 10.1161/CIR.0000000000000456 · DOI · Paper page
  46. Lin GA Kazi D DS Jih J et al. Inclisiran and bempedoic acid for patients with heterozygous familial hypercholesteremia and for secondary prevention of ASCVD: effectiveness and value; final evidence report. Institute for Clinical and Economic Review; 2021. Accessed March 1 2022. https://icer.org/wp-content/uploads/2020/10/ICER_High-Cholesterol_Final-Evidence-Report_030221.pdf.
  47. Appel, LJ, Champagne, CM, Harsha, DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–2093.
  48. 10.1056/NEJM200101043440101 · DOI · Paper page
  49. 10.1016/S0140-6736(04)16980-8 · DOI · Paper page
  50. 10.1161/HYP.0000000000000065 · DOI · Paper page
  51. 10.1161/cir.0b013e318277d6a0 · DOI · Paper page
  52. 10.1161/CIR.0000000000000095 · DOI · Paper page
  53. 10.1161/HYP.0000000000000018 · DOI · Paper page
  54. 10.1161/CIR.0b013e31821daaf6 · DOI · Paper page
  55. 10.1161/CIR.0000000000001063 · DOI · Paper page
  56. 10.1016/j.jacc.2020.05.037 · DOI · Paper page
  57. 10.1161/01.cir.0000437739.71477.ee · DOI · Paper page
  58. 10.1056/NEJMoa1603827 · DOI · Paper page
  59. 10.1056/NEJMoa1607141 · DOI · Paper page
  60. 10.1056/NEJMoa1915922 · DOI · Paper page
  61. 10.1056/NEJMoa070829 · DOI · Paper page
  62. 10.1161/CIR.0000000000000564 · DOI · Paper page
  63. 10.1161/CIRCULATIONAHA.106.180945 · DOI
  64. 10.1161/CIR.0000000000001063 · DOI · Paper page
  65. 10.1136/heartjnl-2017-312832 · DOI · Paper page
  66. 10.1161/01.CIR.0000121360.31954.1F · DOI · Paper page
  67. 10.1177/2047487314561168 · DOI · Paper page
  68. 10.1161/CIR.0000000000000749 · DOI · Paper page
  69. Dibben, G, Faulkner, J, Oldridge, N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2021;11:CD001800.
  70. 10.1371/journal.pone.0177658 · DOI
  71. 10.1161/CIR.0000000000000931 · DOI · Paper page
  72. Feres, F, Costa, RA, Abizaid, A, et al. Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial. JAMA. 2013;310:2510–2522.
  73. 10.1161/CIRCULATIONAHA.120.050304 · DOI
  74. 10.1016/j.jacc.2020.09.011 · DOI · Paper page
  75. 10.1161/CIR.0000000000000651 · DOI
  76. 10.1161/CIR.0000000000001038 · DOI · Paper page
  77. 10.1136/bmj.324.7329.71 · DOI · Paper page
  78. 10.1093/eurheartj/ehz425 · DOI · Paper page
  79. 10.1161/JAHA.120.019017 · DOI
  80. 10.1001/jama.2012.12559 · DOI · Paper page
  81. 10.1161/CIR.0000000000001063 · DOI · Paper page
  82. 10.1161/CIR.0000000000001038 · DOI · Paper page
  83. 10.1161/CIR.0000000000000549 · DOI · Paper page
  84. 10.1161/CIR.0000000000000665 · DOI · Paper page
  85. 10.1161/cir.0b013e318277d6a0 · DOI · Paper page
  86. 10.1056/NEJM200001203420301 · DOI · Paper page
  87. 10.1161/CIR.0000000000001063 · DOI · Paper page
  88. Molad, Y, Reibman, J, Levin, KI, et al. A new mode of action for an old drug: colchicine decreases surface expression of adhesion molecules on both neutrophils (PMNs) and endothelium [abstract]. Arthritis Rheum. 1992;35(abstract):S35.
  89. 10.1093/eurheartj/ehy504 · DOI
  90. 10.1161/cir.0b013e318277d6a0 · DOI · Paper page
  91. 10.1056/NEJMoa1916370 · DOI · Paper page
  92. 10.1161/cir.0b013e318277d6a0 · DOI · Paper page
  93. 10.1161/CIR.0000000000001038 · DOI · Paper page
  94. 10.1161/CIR.0000000000000095 · DOI · Paper page
  95. 10.1056/NEJMoa1916370 · DOI · Paper page
  96. 10.1056/NEJMoa1100356 · DOI · Paper page
  97. 10.1056/NEJMoa1915922 · DOI · Paper page
  98. 10.1056/NEJMoa1205361 · DOI · Paper page
  99. 10.1161/CIR.0000000000001038 · DOI · Paper page
  100. 10.1056/NEJMoa1205361 · DOI · Paper page
  101. 10.1056/NEJMoa2206606 · DOI · Paper page
  102. 10.1161/CIRCULATIONAHA.120.049755 · DOI · Paper page
  103. 10.1161/CIRCULATIONAHA.117.031907 · DOI · Paper page
  104. 10.1161/CIRCULATIONAHA.113.006689 · DOI · Paper page
  105. 10.1056/NEJMoa0804626 · DOI · Paper page
  106. 10.1056/NEJMoa2112299 · DOI · Paper page
  107. 10.1161/CIR.0000000000001038 · DOI · Paper page
  108. 10.1016/S0140-6736(16)32052-9 · DOI · Paper page
  109. Gallo, M, Blitzer, D, Laforgia, PL, et al. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: a meta-analysis. J Thorac Cardiovasc Surg. 2020;S0022–5223(0020)30888-30886.
  110. 10.1161/CIRCULATIONAHA.109.911669 · DOI · Paper page
  111. Lee, KM, Kim, MH, Choi, SY, et al. Twelve versus 30 month dual antiplatelet therapy after percutaneous coronary intervention using national health insurance review & assessment (HIRA) database. Eur Heart J. 2016;37:667.
  112. 10.1056/NEJMoa1610227 · DOI · Paper page
  113. 10.1161/CIR.0000000000000564 · DOI · Paper page
  114. 10.1016/j.amjcard.2016.02.034 · DOI
  115. 10.1016/j.cjca.2016.01.009 · DOI
  116. 10.2340/20030711-1000001 · DOI
  117. 10.1161/CIR.0000000000001029 · DOI · Paper page
  118. 10.1161/CIR.0000000000001038 · DOI · Paper page
  119. 10.1016/j.jacc.2020.11.022 · DOI · Paper page
  120. 10.1161/CIR.0000000000001063 · DOI · Paper page
  121. 10.1161/CIR.0000000000000923 · DOI · Paper page
  122. 10.1161/CIR.0000000000001038 · DOI · Paper page
  123. 10.1136/heartjnl-2020-318119 · DOI
  124. 10.1161/CIR.0000000000001056 · DOI
  125. 10.1161/CIR.0000000000000772 · DOI · Paper page
  126. Bogana Shanmugam, V, Wong, DT, Rashid, H, et al. Bleeding outcomes after non-emergency percutaneous coronary intervention in the very elderly. J Geriatr Cardiol. 2017;14:624–631.
  127. 10.1016/j.jacc.2004.06.068 · doi:10.1016/j.jacc.2004.06.068 · Paper page
  128. 10.1161/CIR.0000000000001038 · DOI · Paper page
  129. 10.1056/NEJMoa1915925 · DOI · Paper page
  130. 10.1161/CIR.0000000000000695 · DOI · Paper page
  131. 10.1161/CIR.0000000000000625 · DOI · Paper page
  132. 10.1016/j.jacc.2021.06.011 · DOI · Paper page
  133. 10.1002/ehf2.12329 · DOI
  134. 10.1161/CIR.0000000000001038 · DOI · Paper page
  135. 10.1016/j.healun.2013.06.023 · DOI
  136. 10.1161/CIR.0000000000000456 · DOI · Paper page
  137. 10.1161/CIR.0000000000000456 · DOI · Paper page
  138. 10.1056/NEJMoa1915922 · DOI · Paper page
  139. 10.1136/openhrt-2020-001499 · DOI
  140. 10.18549/PharmPract.2015.02.575 · DOI
  141. 10.1186/s12933-015-0296-y · DOI · Paper page
  142. 10.1056/NEJMoa1916370 · DOI · Paper page

Cited by

See all 1,598

Metadata

Authors
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., Kazi, D. S., Kolte, D., Kumbhani, D. J., LoFaso, J., Mahtta, D., Mark, D. B., Minissian, M., Navar, A. M., Patel, A. R., Piano, M. R., Rodriguez, F., Talbot, A. W., Taqueti, V. R., Thomas, R. J., van Diepen, S., Wiggins, B., & Williams, M. S.
Affiliations
  • ACC/AHA representative.
  • National Lipid Association (US)
  • Preventive Cardiovascular Nurses Association representative.
  • Former Joint Committee on Clinical Practice Guideline member; current member during the writing effort.
  • Society for Cardiovascular Angiography and Interventions (US)
  • Patient representative/lay stakeholder.
  • American Society for Preventive Cardiology representative.
  • AHA/ACC Joint Committee on Clinical Data Standards.
  • American College of Clinical Pharmacy (US)
  • AHA/ACC Joint Committee on Performance Measures.
Venue
Circulation
Published
2023-08-29
Volume
148
Issue
9
Pages
e9-e119
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4384922756
Cited by
1,598
References
1,177
Citations by year
2026: 535 · 2025: 584 · 2024: 416 · 2023: 63
FWCI
426.88
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Circulation (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • eCommons - AKU (Aga Khan University) (submittedVersion, cc-by-nc-nd)
Funders
  • American Heart Association
  • Office of Science
  • National Heart, Lung, and Blood Institute (K01HL144607)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
stable coronary artery disease, guideline-directed therapy, revascularization, shared decision-making, team-based care, social determinants of health, cardiovascular events, patient follow-up, cost-effectiveness
MeSH terms
American Heart Association, Cardiology, Coronary Disease, Humans, United States, Myocardial Ischemia, Proliferating Cell Nuclear Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. https://app.cochat.ai/papers/10.1161/cir.0000000000001168
The paper
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., Kazi, D. S., Kolte, D., Kumbhani, D. J., LoFaso, J., Mahtta, D., Mark, D. B., Minissian, M., Navar, A. M., Patel, A. R., . . . Williams, M. S. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. https://doi.org/10.1161/cir.0000000000001168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.